The combination of a serotonin reuptake inhibitor and Amoxapine
Details for Australian Patent Application No. 2004269857 (hide)
International Classifications
Event Publications
23 March 2006 PCT application entered the National Phase
PCT publication WO2005/023266 Priority application(s): WO2005/023266
13 April 2006 Amendment Made
The nature of the amendment is: Delete priority details 60/500,792 04 Sep 2003 US 2004269858 H. Lundbeck A/S The nature of the amendment is: Delete priority details 60/500,809 04 Sep 2003 US 2004272186 Trustees of Boston University; BTU International, Inc The nature of the amendment is: Amend the invention title to read Process for solid oxide fuel cell manufacture
19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004269858-The combination of a serotonin reuptake inhibitor and Loxapine
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser